Bone marrow neoplastic

Bone marrow - neoplastic myeloid


WHO-HAEM5 and ICC comparison - MDS / MPN

Last author update: 1 August 2011
Last staff update: 27 April 2023

Copyright: 2002-2023,, Inc.

PubMed Search: WHO classification MDS/MPN [title]

Nikhil Sangle, M.D.
Page views in 2022: 928
Page views in 2023 to date: 473
Cite this page: Sangle N. WHO-HAEM5 and ICC comparison - MDS / MPN. website. Accessed June 1st, 2023.
Definition / general
  • World Health Organization (WHO) classification of disorders which bridge the myelodysplastic (MDS) and myeloproliferative neoplasm (MPN) categories at initial presentation
  • Have morphologic dysplasia and proliferative advantage of one or more of the myeloid differentiating cell lines
  • Diagnosis requires correlation of bone marrow and peripheral blood findings with clinical, genetic and other laboratory information (Semin Diagn Pathol 2003;20:154)
World Health Organization classification
WHO 2008 classification
  • 4.1 Chronic myelomonocytic leukemia
  • 4.2 Juvenile myelomonocytic leukemia
  • 4.3 Atypical chronic myeloid leukemia
  • 4.4 MDS/MPN, unclassifiable

WHO 2001 classification
  • Atypical chronic myeloid leukemia
  • Chronic myelomonocytic leukemia
  • Juvenile myelomonocytic leukemia
  • Myelodysplastic / myeloproliferative disease, unclassifiable
Additional references
Back to top
Image 01 Image 02